期刊文献+

56例子痫前期产妇外周血和胎盘中PLGF和sVEGFR-1的临床意义 被引量:10

Clinical significance of placental growth factor and soluble vascular endothelial growth factor receptor-1 in peripheral blood and placenta of 56 pregnant women with pre-eclampsia
下载PDF
导出
摘要 目的:探讨子痫前期产妇外周血和胎盘中胎盘生长因子(PLGF)和可溶性血管内皮生长因子受体-1(sVEGFR-1)的相关性及临床意义。方法:选择2017年1月—2019年12月在本院妇产科住院的轻度子痫前期(轻度组)、重度子痫前期孕产妇(重度组)各56例,同期本院就诊正常孕产妇56例(正常组),酶联免疫吸附试验法检测产妇分娩时外周血清PLGF和sVEGFR-1蛋白水平,PR-PCR测定胎盘PLGF和sVEGFR-1 mRNA水平,分析孕产妇病情及妊娠结局。结果:血清和胎盘组织中PLGF蛋白水平均重度组<轻度组<正常组,血清和胎盘组织中sVEGFR-1蛋白水平重度组>轻度组>正常组(均P<0.05)。子痫前期患者血清PLGF和胎盘PLGF蛋白水平与24h蛋白尿、收缩压和舒张压均负相关,血清和胎盘sVEGFR-1蛋白水平与24h蛋白尿、收缩压和舒张压均正相关(均P<0.05)。正常组、轻度组和重度组分别有1例、6例和15例围生儿出现临床结局不良(P<0.05),妊娠结局不良产妇外周血清和胎盘PLGF mRNA水平均较妊娠结局正常孕妇低,血清和胎盘sVEGFR-1蛋白水平较妊娠结局正常孕妇高(均P<0.05)。结论:子痫前期孕产妇外周血和胎盘组织PLGF和sVEGFR-1水平可能与PE病情程度及围产儿结局有相关性。 Objective:To investigate the correlation and clinical significance of placental growth factor(PLGF)and soluble vascular endothelial growth factor receptor-1(sVEGFR-1)in peripheral blood and placenta of pregnant women with pre-eclampsia.Methods:From January 2017 to December 2018,56 pregnant women with severe pre-eclampsia were included in group A,56 pregnant women with mild pre-eclampsia were selected in group B,and 56 normal pregnant women were selected in group C.The protein levels of PLGF and sVEGFR-1 in peripheral blood were detected by enzyme-linked immunosorbent assay(ELISA).The protein levels of PLGF and sVEGFR-1 mRNA in placenta was determined by PR-PCR.The state of disease and pregnancy outcomes of these women was analyzed.Results:The PlGF protein level in serum and placental tissues of the women in group A was the lowest,and that of the women in group C was the highest.The SVEGFR-1 protein level in serum and placental tissues of the women in group A was the highest,and that of the women in group C was the lowest(all P<0.05).The protein levels of PLGF in serum and placental of the women with pre-eclampsia were negatively correlated with their 24h proteinuria value,and systolic and diastolic blood pressure.The protein levels of SVEGFR-1 in serum and placental of the women with pre-eclampsia were positively correlated with their 24h proteinuria,and systolic and diastolic blood pressure(all P<0.05).There were 1 perinatal infant with adverse clinical outcomes in group C,6 perinatal infants with adverse clinical outcomes in group B,and 15 perinatal infants with adverse clinical outcomes in group A(P<0.05).The levels of PLGF mRNA in serum and placental of the women with adverse pregnancy outcomes were significant lower than those of women with normal pregnancy outcomes,but the levels of SVEGFR-1 protein in serum and placental of the women with adverse pregnancy outcomes were significant higher than those of women with normal pregnancy outcomes(all P<0.05).Conclusion:The levels of PLGF and sVEGFR-1 in peripheral
作者 闵治红 杜巧玲 MIN Zhihong;DU Qiaoling(The First Maternity and Infant Hospital Affiliated to Tongji University School of Medicine, Shanghai, 201204)
出处 《中国计划生育学杂志》 2021年第2期350-354,共5页 Chinese Journal of Family Planning
关键词 子痫前期 胎盘生长因子 可溶性血管内皮生长因子受体-1 围产儿结局 Pre-eclampsia Placental Growth Factor Soluble Vascular Endothelial Growth Factor Receptor-1 Outcomes of perinatal infant
  • 相关文献

参考文献5

二级参考文献63

  • 1林红.妊娠期糖代谢异常对母婴结局的影响[J].广西医学,2006,28(10):1571-1573. 被引量:5
  • 2American College of Obstetricians and Gynecologists; Task Force on Hypertension in Pregnancy.Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists' Task Force on Hypertension in Pregnancy [J]. Obstet Gynecol, 2013, 122(5):1122-1131. 被引量:1
  • 3Magee LA, Pels A, Helewa M, et al.Canadian Hypertensive Disorders of Pregnancy Working Group. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy: executive summary[J]. J Obstet Gynaecol Can, 2014, 36(5):416-441. 被引量:1
  • 4Visintin C, Mugglestone MA, Almerie MQ, et al. Management of hypertensive disorders during pregnancy: summary of NICE guidance[J]. BMJ, 2010, 341 :c2207. 被引量:1
  • 5Lowe SA, Bowyer L, Lust K, et al. The SOMANZ Guidelines for the Management of Hypertensive Disorders of Pregnancy 2014[J]. Aust N Z J Obstet Gynaecol, 2015, 55(1):11-16. 被引量:1
  • 6Campos-Outcah D Sr. US Preventive Services Task Force: the gold standard of evidence-based prevention[J]. J Fam Pract, 2005, 54(6):517-519. 被引量:1
  • 7Magee LA, Hdewa M, Momquin JM, et al. Diagnosis, evaluation,and management of the hypertensive disorders of pregnancy[J]. J Obstet Gynaeeol Can, 2008, 30 (Suppl): S1-48. 被引量:1
  • 8Cote AM, Brown MA, Laln E, et al. Diagnostic accuracy of urinary spot protein: creatiniue ratio for proteinuria in hypertensive pregnant women: systematic review[J]. BMJ, 2008, 336(7651): 1003-1006. 被引量:1
  • 9Churchill D, Beevers GD, Meher S, et al, Diuretics for preventing pre-eclampsia[J]. Cochrane Database Syst Rev, 2007, 24 (1):CD004451. 被引量:1
  • 10McCoy S, Baldwin K. Pharmacotherapeutie options for the treatment of preeelampsia[J]. Am J Health Syst Pharm, 2009, 66(4):337-344. 被引量:1

共引文献1236

同被引文献131

引证文献10

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部